FDA
approval
· 2016-05-16
FDA Approved: RUFINAMIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved Glenmark's original application for Rufinamide, providing a generic version of the anticonvulsant. Rufinamide is indicated as adjunctive therapy fo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RUFINAMIDE (RUFINAMIDE)